Buy Iovance Biotherapeutics Stock | IOVA Stock Price & Latest News | Public
IOVA

Iovance Biotherapeutics

$0.00 (0.00%)Today

    About IOVA

    Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utiliz...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.18
    -0.37
    -0.55
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.48

    Actual EPS
    Q4 2020

    Stats

    Market Cap$4,73B
    Volume26,68k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$41.49
    1 Year Low$17.78
    Open$33.34
    High$33.61
    Low$32.86

    Buy any stock with any amount of money.

    Download the App
    Download the app